Trial record 2 of 123 for:    diabetes and quality and open and active | Open Studies

The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes. (4301)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2007 by Rabin Medical Center.
Recruitment status was  Not yet recruiting
Information provided by:
Rabin Medical Center Identifier:
First received: June 25, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted

Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. The study will be conducted in a crossover manner: one group starting with the intensive arm followed by the non intensive arm and vice versa. Blood glucose, HbA1C, Fructosamine, 3 days continuous glucose monitoring system (CGMS), total daily insulin dose, fasting lipid profile, body impedance and BMR will be measured. Self esteem and quality of life questionnaires will be filled.

Condition Intervention
Type 1 Diabetes
Behavioral: Intensive Physical activity
Behavioral: Control- regular physical activity

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Randomized,Controlled,Open,Cross-Over Intervention Study for Evaluating the Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.

Resource links provided by NLM:

Further study details as provided by Rabin Medical Center:

Primary Outcome Measures:
  • HbA1C [ Time Frame: 0,3 monthes ]
  • fructosamine [ Time Frame: 0,3 monthes ]

Secondary Outcome Measures:
  • Body composition & BMR [ Time Frame: 0,3 monthes ]
  • Self esteem & QOL questionnaires [ Time Frame: o, 3 monthes ]
  • 3 days CGMS & SBGM profile [ Time Frame: 0,3 monthes ]

Estimated Enrollment: 2007
Study Start Date: July 2007
Estimated Study Completion Date: July 2009
Detailed Description:

Randomized, controlled, open, comparative, cross-over, intervention study in 50 children with type 1 diabetes.


Primary objective To evaluate the efficacy and safety of physical activity for metabolic control in children with type I diabetes.

Secondary objectives

  1. To characterize the severity and pattern of occurrence of hypo and hyperglycemic episodes during and after exercise program in type I diabetic children.
  2. To evaluate changes in insulin sensitivity during and after periods of exercise in type I diabetic children.
  3. To evaluate the short term effect of exercise on BMI and body composition in type I diabetic children.
  4. To evaluate the short term effect of exercise on lipid profile in type I diabetic children.
  5. To evaluate differences in self esteem and quality of life between exercising and non exercising type I diabetic children.


Children will be randomly allocated into two groups of 25.The study will be conducted in a crossover manner:one group starting with the intensive arm followed by the non intensive arm and vice versa.


  1. The study will have an intensive arm and a non intensive arm, each lasting 12 weeks.
  2. Children fulfilling the inclusion and exclusion criteria will be randomly assigned to two groups. Each group will include 25 patients.
  3. Participants will fill questionnaires regarding physical activity.
  4. The first group will start with the intensive arm, followed by one month washout, and then the non intensive arm.
  5. The second group will start the study with the non intensive arm, followed by one month washout and then the intensive arm .
  6. The intensive arm will consist of an exercise program which will include high intensity progressive exercise (75% maximum age adjusted heart rate HRmax) 3 days a week for 90 minutes. The 90 min exercise will be a combination of aerobic exercise 45min. and resistance exercise 45 min.
  7. The exercise program will be planned and carried out by professional sports instructors.
  8. During the non intensive arm the participants will resume regular daily activity. They will keep records of their weekly physical activity and will get a weekly phone call from the treating doctor, addressing specifically physical activity performed during the past week and glucose levels before and after exercise.
  9. The following parameters will be measured for both groups at the beginning and the end of the intensive and non intensive arm and once again 12 weeks afterwards : Weight, height, pulse, blood pressure, waist circumference, skin folds, HbA1C , fructosamine ,3 days CGMS +3 day SBGM profile (will be measured to 40% of participants chosen randomly) ,total daily insulin dose ,blood sample for fasting lipid profile ,Body impedance and BMR , self esteem and quality of life questionnaires .
  10. Study participants will be required to measure blood glucose by glucometer at least 4 times a day and to record hypo and hyperglycemic events and their severity.

15.Both children and investigators will be blinded to CGMS results. 16.During the 3 day CGMS recording, the children's parents will be asked to monitor SBGM once during the night (in the intensive arm, following the exercise day).


Ages Eligible for Study:   8 Years to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Type I diabetic children
  2. Tanner stage II-IV
  3. Patients of the Schneider's national institute of childhood diabetes. Duration of diabetes
  4. more than one year.
  5. HbA1C between 8 and 12 at time 0.
  6. Mandatory 4 daily self blood glucose measurements and daily recording of adverse events.
  7. A signed informed consent of the parents and child.

Exclusion Criteria:

  1. Additional chronic significant disease such as cardiac, liver, renal disease .
  2. Children who exercise regularly more than 180 min per week.
  3. Cardiac symptoms: history of chest pain , syncope , palpitations or dyspnea during exercise.
  4. Eating disorders.
  5. Participation in a study during the past month.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00491465

Contact: Ravital Nimri, MD 972-39253778 ext direct

Schnider children's medical center Not yet recruiting
Petach-Tikva, Israel
Principal Investigator: Ravital Nimri, MD         
Principal Investigator: Moshe Phillip, Prof.         
Sub-Investigator: Rachel Frumkin, MD         
Sub-Investigator: Neomi Weintrob, MD         
Sub-Investigator: Shlomit Shalitin, MD         
Sub-Investigator: Nesia Nagelberg, MA         
Sponsors and Collaborators
Rabin Medical Center
Principal Investigator: Ravital Nimri, MD Rabin Medical Center
Principal Investigator: Moshe Phillip, Prof Rabin Medical Center
  More Information

No publications provided Identifier: NCT00491465     History of Changes
Other Study ID Numbers: rmc074301ctil
Study First Received: June 25, 2007
Last Updated: June 25, 2007
Health Authority: Israel: Clalit Health Services

Keywords provided by Rabin Medical Center:
Type 1 Diabetes, physical activity, pediatric, metabolic control

Additional relevant MeSH terms:
Diabetes Mellitus, Type 1
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases processed this record on September 22, 2014